Cancer IVD Market Size, Share, Competitive Landscape and Trend Analysis Report by Product Type, by TECHNIQUE, by CANCER TYPE and by END USER : Global Opportunity Analysis and Industry Forecast, 2023-2032

• Reagents
• Instruments
• Software and Services

• Blood Testing
• Tissue Diagnostics

• Breast Cancer
• Colorectal Cancer
• Lung Cancer
• Prostate Cancer
• Other Cancer Types

• Standalone Laboratory
• Hospitals
• Academic and Medical Schools
• Other End User

• North America  (U.S., Canada, Mexico)
• Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
• Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
• LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)

Abbott Laboratories, Illumina, Inc., Olympus Corporation, Siemens Healthineers, Roche Diagnostics, Agilent Technologies, Hologic, Inc., Thermo Fisher Scientific, Qiagen NV, GlaxoSmithKline